Literature DB >> 23955072

Generalized pustular eruptions: time to adapt the disease taxonomy to the genetic architecture?

Alexander A Navarini1, Laurence Valeyrie-Allanore2, Niovi Setta-Kaffetzi1, Jonathan N Barker3, Francesca Capon1, Daniel Creamer4, Jean-Claude Roujeau2, Peggy Sekula5, Michael A Simpson1, Richard C Trembath1, Maja Mockenhaupt6, Catherine H Smith7.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23955072     DOI： 10.1038/jid.2013.349

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.

Authors:  Alexander A Navarini; Laurence Valeyrie-Allanore; Niovi Setta-Kaffetzi; Jonathan N Barker; Francesca Capon; Daniel Creamer; Jean-Claude Roujeau; Peggy Sekula; Michael A Simpson; Richard C Trembath; Maja Mockenhaupt; Catherine H Smith
Journal:  J Invest Dermatol       Date:  2013-01-28       Impact factor: 8.551

Review 2.  Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.

Authors:  M A Martin; T E Klein; B J Dong; M Pirmohamed; D W Haas; D L Kroetz
Journal:  Clin Pharmacol Ther       Date:  2012-02-29       Impact factor: 6.875

3.  The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist.

Authors:  Kazumitsu Sugiura; Akemi Takemoto; Michiya Yamaguchi; Hidetoshi Takahashi; Yukiko Shoda; Teruyuki Mitsuma; Kenshiro Tsuda; Emi Nishida; Yaei Togawa; Kimiko Nakajima; Akihiro Sakakibara; Shigeo Kawachi; Makoto Shimizu; Yasutomo Ito; Takuya Takeichi; Michihiro Kono; Yasushi Ogawa; Yoshinao Muro; Akemi Ishida-Yamamoto; Shigetoshi Sano; Hiroyuki Matsue; Akimichi Morita; Hitoshi Mizutani; Hajime Iizuka; Masahiko Muto; Masashi Akiyama
Journal:  J Invest Dermatol       Date:  2013-05-22       Impact factor: 8.551

4.  Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris.

Authors:  Dorottya M Berki; Satveer K Mahil; A David Burden; Richard C Trembath; Catherine H Smith; Francesca Capon; Jonathan N Barker
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

5.  Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes.

Authors:  Niovi Setta-Kaffetzi; Alexander A Navarini; Varsha M Patel; Venu Pullabhatla; Andrew E Pink; Siew-Eng Choon; Michael A Allen; A David Burden; Christopher E M Griffiths; Marieke M B Seyger; Brian Kirby; Richard C Trembath; Michael A Simpson; Catherine H Smith; Francesca Capon; Jonathan N Barker
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551
  5 in total
  1 in total

1.  A Case of Ceftriaxone-Induced Acute Generalized Exanthematous Pustulosis/Generalized Pustular Psoriasis Overlap.

Authors:  Jianfeng Zheng; Yunlu Gao; Xuemei Yi; Yangfeng Ding
Journal:  Case Rep Dermatol       Date:  2018-03-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.